MARKET

ENTX

ENTX

Entera Bio Ltd
NASDAQ
1.570
-0.200
-11.30%
After Hours: 1.550 -0.02 -1.27% 16:15 01/06 EST
OPEN
1.770
PREV CLOSE
1.770
HIGH
1.810
LOW
1.570
VOLUME
1.48M
TURNOVER
--
52 WEEK HIGH
3.220
52 WEEK LOW
1.501
MARKET CAP
72.00M
P/E (TTM)
-6.4292
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENTX last week (1229-0102)?
Weekly Report · 1d ago
Top Executive Makes Bold New Move on Entera Bio Stock
TipRanks · 12/31/2025 02:03
Weekly Report: what happened at ENTX last week (1222-1226)?
Weekly Report · 12/29/2025 09:08
Analysts’ Top Healthcare Picks: Cerus (CERS), Entera Bio (ENTX)
TipRanks · 12/23/2025 18:10
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
TipRanks · 12/23/2025 13:40
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
Barchart · 12/23/2025 07:30
Entera Bio announces new data on long-acting PTH tablet
TipRanks · 12/22/2025 13:41
Entera Bio Announces New Validating In Vivo Pharmacokinetic And Pharmacodynamic Data That Supports Development Of Proprietary Long-Acting PTH Analog Using N-Tab Platform For Patients With Hypoparathyroidism
Benzinga · 12/22/2025 13:33
More
About ENTX
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.

Webull offers Entera Bio Ltd stock information, including NASDAQ: ENTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENTX stock methods without spending real money on the virtual paper trading platform.